LMR Partners »

Celldex Therapeutics shares owned by LMR Partners

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by LMR Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.4M 200k 41.97
2021-03-31 $522k 25k 20.59

More positions owned by LMR Partners

Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microstrategy Cl A New Put Option (MSTR)
Ishares Tr National Mun Etf Put Option (MUB)
Vaneck Etf Trust Semiconductr Etf (SMH)
Spdr Ser Tr S&p Oilgas Exp Put Option (XOP)
NVIDIA Corporation Put Option (NVDA)
Capri Holdings SHS (CPRI)
Tripadvisor (TRIP)
Microsoft Corporation (MSFT)
BP Sponsored Adr (BP)
Advanced Micro Devices Call Option (AMD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr China Lg-cap Etf (FXI)
Stellantis SHS Put Option (STLA)

View all positions for LMR Partners

Top funds holding Celldex Therapeutics

FMR
Wellington Management Company
BlackRock
Vanguard Group
Eventide Asset Management
T. Rowe Price Associates
Kynam Capital Management
Bellevue Group
Pictet Asset Management Holding SA
Geode Capital Management
Rock Springs Capital Management
Point72 Asset Management
Marshall Wace
Redmile Group
Commodore Capital

View all funds holding Celldex Therapeutics